As of 2025-05-15, the Intrinsic Value of Pharmagreen Biotech Inc (PHBI) is 0.00 USD. This PHBI valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.00 USD, the upside of Pharmagreen Biotech Inc is -47.70%.
The range of the Intrinsic Value is 0.00 - 0.00 USD
Based on its market price of 0.00 USD and our intrinsic valuation, Pharmagreen Biotech Inc (PHBI) is overvalued by 47.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.00 - 0.00 | 0.00 | -47.7% |
| DCF (Growth 10y) | 0.00 - 0.00 | 0.00 | -12.1% |
| Fair Value | -0.01 - -0.01 | -0.01 | -787.93% |
| EPV | (0.01) - (0.01) | (0.01) | -1284.1% |
| DDM - Stable | (0.02) - (0.03) | (0.02) | -2220.1% |
| DDM - Multi | (0.01) - (0.02) | (0.02) | -1640.4% |
| Market Cap (mil) | 0.73 |
| Beta | -0.04 |
| Outstanding shares (mil) | 663.65 |
| Enterprise Value (mil) | 1.09 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.09% |
| Cost of Debt | 5.00% |
| WACC | 5.30% |